| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding | |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | Entrez:930 MIM:107265 HGNC:HGNC:1633 Ensembl:ENSG00000177455 AllianceGenome:HGNC:1633 | |
| Description | CD19 molecule | |||||
| GTO ID | GTC2297 |
| Trial ID | NCT04250324 |
| Disease | Large B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BZ019 |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Study of Safety and Efficacy of BZ019 in (R/R) Large B-cell Lymphoma |
| Year | 2020 |
| Country | China |
| Company sponsor | Shanghai Cell Therapy Group Co., Ltd |
| Other ID(s) | XY2019028-EC-1 |
| Cohort 1 | |||||||||||
|
|||||||||||